from Section II - Executive Dysfunction in the Neurodevelopmental and Acquired Disorders
Published online by Cambridge University Press: 05 October 2012
Cancer is the leading cause of death by disease in children under the age of 15 years. Brain tumors and acute lymphoblastic leukemia (ALL) are the two most common forms of pediatric cancer, collectively accounting for more than half of all newly diagnosed cases annually. Most research into the neuropsychological sequelae of pediatric cancer and its associated treatment has involved the study of ALL and brain tumors because of their high prevalence as well as their greater associated neuropsychological morbidity. This morbidity has become increasingly prevalent as survival rates for ALL and brain tumors have improved over the last several decades.
The neuropsychological sequelae of pediatric cancer extend into adolescence and adulthood and are not only associated with the cancer itself but the treatments employed, including surgical intervention, chemotherapy, cranial/craniospinal radiation therapy (CRT), or a combination of these treatments. Other disease- and treatment-related outcome moderators include neurologic complications (e.g., intracranial bleeding, hydrocephalus, leukoencephalopathy) and sensorimotor deficits related to the primary disease and/or to iatrogenic effects. CRT, in particular, has been one of the greatest contributors to improved survival in the treatment of brain tumors and higher risk forms of ALL, but it has also been associated with numerous neurologic and neurocognitive effects that vary according to the extent and location of CNS involvement, size of area irradiated, and total dose administered. Intrathecal and high-dose intravenous chemotherapies, particularly methotrexate, are now routinely employed without adjuvant radiation in the treatment of standard-risk ALL. While evidence regarding the neuropsychological risk associated with such isolated chemotherapy is mixed, it is generally acknowledged that both intrathecal chemotherapy and the chemotherapy agents administered in the treatment of various brain tumors have a less significant effect on neuropsychological outcome than does CRT.
To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.